Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

被引:0
|
作者
Savard, Josee [1 ,2 ,3 ,8 ]
Filion, Catherine [2 ,3 ]
Brearty, Claudia Mc [1 ,2 ,3 ]
Caplette-Gingras, Aude [2 ,4 ]
Chiquette, Jocelyne [2 ,4 ,5 ]
Dorval, Michel [3 ,6 ,7 ]
机构
[1] Univ Laval, Sch Psychol, Quebec City, PQ, Canada
[2] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada
[3] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, CHU Quebec, Ctr Maladies Sein, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Quebec City, PQ, Canada
[6] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[7] CISSS Chaudiere Appalaches Res Ctr, Levis, PQ, Canada
[8] Univ Laval, Hop Enfant Jesus, Ctr integre cancerol, CHU Quebec, 1401 18e Rue, Quebec City, PQ G1J 1Z4, Canada
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
BRCA1/2 genetic mutation; breast cancer; fear of cancer recurrence; psychological intervention; qualitative study; RISK REDUCTION; THERAPY;
D O I
10.1002/cam4.6889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThere is preliminary evidence suggesting that FCR is a major problem for breast cancer survivors carrying a BRCA1/2 mutation. The goal of this qualitative study, conducted among women who were treated for breast cancer, was to provide a deeper understanding of how FCR is experienced in the context of a genetic predisposition to breast cancer.MethodThree focus groups (90-110 min) were conducted with 19 breast cancer survivors carrying a BRCA1/2 mutation. The semistructured interview probed FCR level and impact, the role FCR played in the decision to have a prophylactic bilateral mastectomy and/or salpingo-oophorectomy, the effect that surgery had on FCR, and the relevance of offering a psychological intervention targeting FCR to this population.ResultsFindings indicated that FCR was a significant issue in these women, even though a majority had undergone a prophylactic surgery. Patients strongly affirmed the need to develop and provide access to FCR interventions that are specifically adapted to the needs of this group.DiscussionThese results suggest that, although being the most effective medical option to reduce the actual risk of local recurrence (or second breast cancer), prophylactic surgery only partially reduces FCR. A psychological intervention targeting specifically FCR would be an appropriate complement to preventive surgery.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study
    Michel, Alexandra
    Dorval, Michel
    Chiquette, Jocelyne
    Savard, Josee
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2024, 22 (01)
  • [2] Fear of Recurrence in Turkish Breast Cancer Survivors: A Qualitative Study
    Inan, Figen Sengun
    Ustun, Besti
    JOURNAL OF TRANSCULTURAL NURSING, 2019, 30 (02) : 146 - 153
  • [3] Survival and recurrence after breast cancer in BRCA1/2 mutation carriers
    El-Tamer, M
    Russo, D
    Troxel, A
    Bernardino, LP
    Mazziotta, R
    Estabrook, A
    Ditkoff, BA
    Schnabel, F
    Mansukhani, M
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : 157 - 164
  • [4] Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers
    Mahmoud El-Tamer
    Donna Russo
    Andrea Troxel
    Lourdes P. Bernardino
    Robert Mazziotta
    Alison Estabrook
    Beth-Ann Ditkoff
    Freya Schnabel
    Mahesh Mansukhani
    Annals of Surgical Oncology, 2004, 11 : 157 - 164
  • [5] Breast Cancer Prevention in BRCA1/2 Mutation Carriers: A Qualitative Review
    Fuller, Sarah
    Liebens, Fabienne
    Carly, Birgit
    Pastijn, Anne
    Rozenberg, Serge
    BREAST JOURNAL, 2008, 14 (06): : 603 - 604
  • [6] Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer
    Ang, Boon Hong
    Ho, Weang Kee
    Wijaya, Eldarina
    Kwan, Pui Yoke
    Ng, Pei Sze
    Yoon, Sook Yee
    Hasan, Siti Norhidayu
    Lim, Joanna M. C.
    Hassan, Tiara
    Tai, Mei-Chee
    Allen, Jamie
    Lee, Andrew
    Taib, Nur Aishah Mohd
    Yip, Cheng Har
    Hartman, Mikael
    Lim, Swee Ho
    Tan, Ern Yu
    Tan, Benita K. T.
    Tan, Su-Ming
    Tan, Veronique K. M.
    Ho, Peh Joo
    Khng, Alexis J.
    Dunning, Alison M.
    Li, Jingmei
    Easton, Douglas F.
    Antoniou, Antonis C.
    Teo, Soo Hwang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1542 - +
  • [7] Rates of BRCA1/2 mutation testing among young survivors of breast cancer
    Kenneth L. Kehl
    Chan Shen
    Jennifer K. Litton
    Banu Arun
    Sharon H. Giordano
    Breast Cancer Research and Treatment, 2016, 155 : 165 - 173
  • [8] Rates of BRCA1/2 mutation testing among young survivors of breast cancer
    Kehl, Kenneth L.
    Shen, Chan
    Litton, Jennifer K.
    Arun, Banu
    Giordano, Sharon H.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (01) : 165 - 173
  • [9] Germline BRCA1 and BRCA2 testing for breast cancer survivors
    Wiggins, Jennifer
    McLoughlin, Anne
    George, Angela
    Ring, Alistair
    Kemp, Zoe
    JOURNAL OF MEDICAL GENETICS, 2020, 57 (08) : 528 - 530
  • [10] Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer
    Kenneth L. Kehl
    Chan Shen
    Jennifer K. Litton
    Banu Arun
    Sharon H. Giordano
    Breast Cancer Research and Treatment, 2016, 159 : 201 - 201